Clinical and serological characteristics of APS patients with and without thrombocytopenia2-150
| Clinical and serological manifestations | Patients with thrombocytopenia (n=40) | Patients without thrombocytopenia (n=131) |
| Thrombosis - arterial | 17 (42.5) | 69 (53) |
| - venous | 18 (45) | 71 (54) |
| Recurrent thrombosis | 25 (62.5) | 80 (61) |
| Miscarriages | 20/35 (57) | 49/112 (44) |
| Livedo reticularis | 10 (25) | 21 (16) |
| Raynaud’s | 3 (7.5) | 7 (5.3) |
| Heart valve involvement | 11 (27.5) | 30 (23) |
| Haemolytic anaemia | 2 (5) | 5 (4) |
| Migraine | 11 (27.5) | 34 (26) |
| Chorea | 2 (5) | 1 (0.8) |
| Epilepsy | 8 (20) | 16 (12) |
| Multiinfarct dementia | 3 (7.5) | 11 (8.5) |
| Positive lupus anticoagulant | 31/37 (83.8) | 87/117 (74) |
| Positive anticardiolipin antibodies | ||
| IgG: | 33 (82.5) | 98 (75) |
| low | 5 (12.5) | 29 (22.1) |
| medium | 12 (30) | 38 (29) |
| high | 16 (40) | 31 (23.7) |
| IgM: | 14 (35) | 33 (25) |
| low | 8 (20) | 18 (13.7) |
| medium | 5 (12.8) | 8 (6.1) |
| high | 1 (2.2) | 7 (5.3) |
↵2-150 Statistical analysis did not show any significant differences in parameters tested in the two groups. Figures in parentheses are percentages.